Effect of Artronat on the Quality of Life of Patient With Osteoarthritis
NCT ID: NCT01356199
Last Updated: 2014-03-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
7 participants
INTERVENTIONAL
2011-10-31
2013-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Study of the Feasibility of Using the Dietary Supplement "ARTNEO" in Patients With Osteoathritis
NCT05975879
Evaluation of the Efficacy of a Turmeric Extract (Arantal®) in Patients With Osteoarthritis of the Knee (Gonarthrosis).
NCT00992004
Kinesiological / Dietary Supplement Intervention in Knee Osteoarthritis
NCT06269549
Assessment of Patients Quality of Life Treated With Three ARTHRUM H 2% Joint Injections
NCT02840422
Real-life Use of BENART TM in Patients With Symptomatic Knee Osteoarthritis
NCT04757051
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
ARTRONAT
ARTRONAT
Dietary supplement containing Glucosamine, Chondroïtine and manganese. 6 per day for 8 months.
PLACEBO
PLACEBO
PLACEBO. 6 per day for 8 months.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
ARTRONAT
Dietary supplement containing Glucosamine, Chondroïtine and manganese. 6 per day for 8 months.
PLACEBO
PLACEBO. 6 per day for 8 months.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* BMI 18.5-30
* osteoarthritis type II or III
Exclusion Criteria
* allergy to one of the component of the supplement
* blood pressure \> 14/8
* history of knee surgery
40 Years
75 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
RDVC Produit de Santé.
UNKNOWN
Association Nationale de Prévention Médicale.
UNKNOWN
Lescuyer Laboratory
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Maurice Cloarec, MD
Role: STUDY_CHAIR
Association Nationale de Prevention Medicale
Dominique Baron, MD
Role: PRINCIPAL_INVESTIGATOR
Hospital Center of Lanion
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Centre Rééducation et Réadaptation Fonctionnelles de Trestel , Centre Hospitalier Pierre-Le-Damany Lannion
Treviou Treguignec, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2011-A00319-32
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.